99久久精品免费观看国产,色网站免费,2021国内精品久久久久久影院,国产免费福利网站,欧美日韩国产精品综合,国内在线精品,国产三级日本三级日产三

CN / EN

News

Technoderma Medicines Dosed TDM-105795 in Phase 1b (MAD) AGA Clinical Trial

Release time: 2022-03-11 Article source: 特科羅

SHANGHAI – February 23 2022  Technoderma Medicines, Inc. (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has begun dosing in its Phase 1b (MAD) clinical trial of topical TDM-105795 solution in patients with Androgenetic Alopecia (AGA). This second clinical trial in the program is a 28-day multiple dose escalation study entitled, “A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group, Multi-Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TDM-105795 in Healthy Male Subjects with Androgenetic Alopecia”. Study objectives are to evaluate the safety and pharmacokinetics of topical TDM-105795 following repeated doses. Two U.S. clinical sites are currently participating in this study.

Arthur P. Bertolino, MD, PhD, MBA, Chief Medical Officer at Technoderma Medicines commented, “We also expect the current study results to guide choice of formulation strength(s) appropriate for a subsequent proof-of-concept (PoC) Phase 2 Androgenetic Alopecia study. The Company anticipates the robust induction of hair growth demonstrated by TDM-105795 in preclinical testing should be observable within several months of initiating treatment.”

“We look to the TDM-105795 AGA program as the first clinical anchor among our pipeline products for treatment of various dermatologic diseases,” said Zengquan Wang, Chief Executive Officer at Technoderma Medicines. “We are working tobring a second pipeline product (Atopic Dermatitis) into clinical testing soon in mid-year.”


朝阳县| 淮阳县| 舞钢市| 阿巴嘎旗| 灵丘县| 扬州市| 金平| 怀远县| 揭阳市| 丰原市| 邢台县| 广西| 洛扎县| 镇坪县| 祁东县| 石棉县| 札达县| 桦南县| 洱源县| 信丰县| 怀化市| 望都县| 乐都县| 民丰县| 太湖县| 泌阳县| 星子县| 新乡县| 新田县| 水富县| 柘荣县| 凌源市| 太保市| 临桂县| 成武县| 保定市| 合阳县| 信宜市| 突泉县| 深泽县| 安塞县|